Health
newsGP – ‘Important’ study shows gout medication can halt coronary disease progression – RACGP
The major clinical trial found use of low dose colchicine reduces heart attacks and the need for coronary stenting or bypass surgery by 30%.
News
The major clinical trial found use of low dose colchicine reduces heart attacks and the need for coronary stenting or bypass surgery by 30%.
Coronary heart disease is the leading cause of death in Australia.
The international study, published in The New England Journal of Medicine, examined the effect of low dose colchicine in patients with chronic coronary disease who were already taking established treatments.The two-year randomised, controlled, double-blind trial, led by GenesisCare i…
-
Noosa News13 hours agoMega-team of heavy horses sets world record at Good Old Days Festival
-
General6 hours agoHow the internet reacted to Brisbane Broncos winning the NRL grand final
-
General17 hours agoEnglish springer spaniels Kelly and Milo helping fight dieback in Western Australia
-
Business22 hours agoTop brokers name 3 ASX shares to buy next week 5 October 2025